INM SEC Filings
SEC filings for INM. Annual and quarterly reports, 8-K events, Form 4 insider filings and 13D/G stake disclosures.
| Form | Filed | Accession |
|---|---|---|
| 10-QAIInMed's MD&A is dominated by distress signals: a going concern warning, a Nasdaq minimum bid price deficiency, the wind-down of its only revenue-generating segment, and widening net losses. | May 7, 2026 | 0001213900-26-052920EDGAR |
| 10-Q | Feb 12, 2026 | 0001213900-26-014996EDGAR |
| 10-QAIA pre-revenue-stage pharma filing dominated by going-concern doubt, continuing losses, a funding gap and a declining commercial segment. | Nov 7, 2025 | 0001213900-25-107152EDGAR |
Never miss a INM filing.
Get an email when INM files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.